What drug-drug interactions should I watch for while hospitalized with acute coronary syndrome?

When you are hospitalized for acute coronary syndrome (ACS), you will likely receive several medications to manage your heart condition and prevent complications. These can include blood thinners (antiplatelets and anticoagulants), heart medications, and possibly drugs for other conditions. Because you may be on many drugs at once, there is a risk of drug-drug interactions (DDIs) — where one drug affects how another works, potentially causing harm or reducing effectiveness. Studies show that hospitalized ACS patients are exposed to many potential DDIs, with one study finding an average of 9 to 10 interactions per patient during the hospital stay ¹⁰. Another study detected over 2,500 potential DDIs among 371 patients ⁵¹¹. The good news is that your hospital team watches for these interactions and adjusts medications to keep you safe. Knowing which combinations are most concerning can help you ask informed questions.

What the research says

Research shows that certain drug combinations are especially common and potentially risky in hospitalized ACS patients. A study in Egypt found that the most frequent serious interaction (category D) was between aspirin and ticagrelor — both are antiplatelet drugs used to prevent blood clots ⁵¹¹. While this combination is often prescribed intentionally for ACS, it increases bleeding risk, so doctors monitor you closely for signs of bleeding. The same study found that the most common moderate interaction (category C) was between ramipril (an ACE inhibitor for blood pressure) and aspirin, which can reduce the effectiveness of ramipril ⁵¹¹.

Other important interactions involve medications you may be taking for other conditions. For example, proton pump inhibitors (PPIs) like omeprazole are often given to protect the stomach, but they can interact with the antiplatelet drug clopidogrel, potentially reducing its effectiveness ⁶. However, PPIs are still commonly prescribed — one study found that nearly half of ACS patients with atrial fibrillation were discharged on a PPI ⁶. If you smoke, your doctor may recommend smoking cessation aids like bupropion or varenicline. A study found that adding these to nicotine replacement therapy (NRT) after ACS was linked to lower mortality, but these drugs can interact with other heart medications, so your doctor will weigh the benefits and risks ⁴.

Blood thinners like heparin and bivalirudin are used during procedures like PCI. The timing of switching from one to another matters: a study found that waiting more than 30 minutes between stopping heparin and starting bivalirudin was linked to higher rehospitalization rates ⁸. Your care team manages these transitions carefully. Also, if you are on an anticoagulant like a NOAC (e.g., apixaban, rivaroxaban) for atrial fibrillation, combining it with antiplatelet drugs increases bleeding risk, and guidelines recommend careful management ⁹.

Overall, the risk of interactions increases with the number of drugs you take, longer hospital stays, and certain conditions like heart failure or kidney disease ⁵¹⁰¹¹. Your doctors and pharmacists use interaction checkers (like Lexi-Interact or Micromedex) to identify and manage these risks ⁵¹⁰¹¹.

What to ask your doctor

• Which blood thinners (antiplatelets or anticoagulants) am I taking, and what signs of bleeding should I watch for?
• Are any of my medications known to interact with each other, and how are you monitoring for that?
• I take a PPI (like omeprazole) for my stomach — could it affect my heart medications?
• If I need help quitting smoking, are bupropion or varenicline safe to use with my current heart drugs?
• How will you manage the timing of switching between heparin and bivalirudin during my procedure?